NOS2 and neoplasm: Second, it has been established by multiple groups that durable anti-tumor immune responses to immunotherapy require intra-tumoral proliferation of T cells (187), a process that may be directly inhibited by RT-induced NOS uncoupling and local BH4 depletion.